SELLAS Life Sciences (SLS) Leases (2019 - 2026)
SELLAS Life Sciences (SLS) reported Leases of $839000.0 for Q1 2026, up 4.09% year-over-year from $806000.0 in Q1 2025, and down 12.88% on a QoQ basis from $963000.0 in Q4 2025.
SELLAS Life Sciences (SLS) has 8 years of Leases data on file, last reported at $839000.0 in Q1 2026.
- Quarterly Leases rose 4.09% year-over-year to $839000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $839000.0 (up 4.09% YoY) and the FY2025 annual result came in at $963000.0, up 4.11% from the prior year.
- Leases eased to $839000.0 in Q1 2026 per SLS's latest filing, from $963000.0 in the prior quarter.
- Across five years, Leases topped out at $1.1 million in Q1 2022 and bottomed at $513000.0 in Q3 2024.
- The 5-year median for Leases is $806000.0 (2025), against an average of $799764.7.
- The widest annual swing landed in 2022, when Leases surged 31.97%; it then slumped 38.4% in 2023.
- Tracing SLS's Leases over 5 years: stood at $874000.0 in 2022, then declined by 1.83% to $858000.0 in 2023, then increased by 7.81% to $925000.0 in 2024, then grew by 4.11% to $963000.0 in 2025, then fell by 12.88% to $839000.0 in 2026.
- Per Business Quant, the three latest SLS Leases figures stand at $839000.0 (Q1 2026), $963000.0 (Q4 2025), and $556000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 83,048.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 61,822.50 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 285.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.69 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 189.30 Mn |
| 10 | SELLAS Life Sciences | 1.61 Bn | 1.61 Bn | - | 839,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 839,000.00 |
| Dec 31, 2025 | 963,000.00 |
| Sep 30, 2025 | 556,000.00 |
| Jun 30, 2025 | 683,000.00 |
| Mar 31, 2025 | 806,000.00 |
| Dec 31, 2024 | 925,000.00 |
| Sep 30, 2024 | 513,000.00 |
| Jun 30, 2024 | 633,000.00 |
| Mar 31, 2024 | 747,000.00 |
| Dec 31, 2023 | 858,000.00 |
| Sep 30, 2023 | 592,000.00 |
| Jun 30, 2023 | 690,000.00 |
| Mar 31, 2023 | 784,000.00 |
| Dec 31, 2022 | 874,000.00 |
| Sep 30, 2022 | 961,000.00 |
| Jun 30, 2022 | 1.05 Mn |
| Mar 31, 2022 | 1.13 Mn |
| Dec 31, 2021 | 723,000.00 |
| Sep 30, 2021 | 767,000.00 |
| Jun 30, 2021 | 812,000.00 |
| Mar 31, 2021 | 854,000.00 |
| Dec 31, 2020 | 896,000.00 |
| Sep 30, 2020 | 911,000.00 |
| Jun 30, 2020 | 1.00 Mn |
| Mar 31, 2020 | 123,000.00 |
| Dec 31, 2019 | 217,000.00 |
| Sep 30, 2019 | 306,000.00 |
| Jun 30, 2019 | 390,000.00 |
| Mar 31, 2019 | 471,000.00 |